In recent years,feature selection(FS)optimization of high-dimensional gene expression data has become one of the most promising approaches for cancer prediction and classification.This work reviews FS and classificati...In recent years,feature selection(FS)optimization of high-dimensional gene expression data has become one of the most promising approaches for cancer prediction and classification.This work reviews FS and classification methods that utilize evolutionary algorithms(EAs)for gene expression profiles in cancer or medical applications based on research motivations,challenges,and recommendations.Relevant studies were retrieved from four major academic databases-IEEE,Scopus,Springer,and ScienceDirect-using the keywords‘cancer classification’,‘optimization’,‘FS’,and‘gene expression profile’.A total of 67 papers were finally selected with key advancements identified as follows:(1)The majority of papers(44.8%)focused on developing algorithms and models for FS and classification.(2)The second category encompassed studies on biomarker identification by EAs,including 20 papers(30%).(3)The third category comprised works that applied FS to cancer data for decision support system purposes,addressing high-dimensional data and the formulation of chromosome length.These studies accounted for 12%of the total number of studies.(4)The remaining three papers(4.5%)were reviews and surveys focusing on models and developments in prediction and classification optimization for cancer classification under current technical conditions.This review highlights the importance of optimizing FS in EAs to manage high-dimensional data effectively.Despite recent advancements,significant limitations remain:the dynamic formulation of chromosome length remains an underexplored area.Thus,further research is needed on dynamic-length chromosome techniques for more sophisticated biomarker gene selection techniques.The findings suggest that further advancements in dynamic chromosome length formulations and adaptive algorithms could enhance cancer classification accuracy and efficiency.展开更多
基金funded by the Ministry of Higher Education of Malaysia,grant number FRGS/1/2022/ICT02/UPSI/02/1.
文摘In recent years,feature selection(FS)optimization of high-dimensional gene expression data has become one of the most promising approaches for cancer prediction and classification.This work reviews FS and classification methods that utilize evolutionary algorithms(EAs)for gene expression profiles in cancer or medical applications based on research motivations,challenges,and recommendations.Relevant studies were retrieved from four major academic databases-IEEE,Scopus,Springer,and ScienceDirect-using the keywords‘cancer classification’,‘optimization’,‘FS’,and‘gene expression profile’.A total of 67 papers were finally selected with key advancements identified as follows:(1)The majority of papers(44.8%)focused on developing algorithms and models for FS and classification.(2)The second category encompassed studies on biomarker identification by EAs,including 20 papers(30%).(3)The third category comprised works that applied FS to cancer data for decision support system purposes,addressing high-dimensional data and the formulation of chromosome length.These studies accounted for 12%of the total number of studies.(4)The remaining three papers(4.5%)were reviews and surveys focusing on models and developments in prediction and classification optimization for cancer classification under current technical conditions.This review highlights the importance of optimizing FS in EAs to manage high-dimensional data effectively.Despite recent advancements,significant limitations remain:the dynamic formulation of chromosome length remains an underexplored area.Thus,further research is needed on dynamic-length chromosome techniques for more sophisticated biomarker gene selection techniques.The findings suggest that further advancements in dynamic chromosome length formulations and adaptive algorithms could enhance cancer classification accuracy and efficiency.
